Sung Jae Jo1, Seung Ho Kim1. 1. Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Haeundae-gu, Busan, Korea.
Abstract
BACKGROUND: To evaluate the association between various radiologic-pathologic findings and oncogenic Kirsten-ras (KRAS) mutation in patients with primary rectal cancer. METHODS: Seventy-five patients with primary rectal cancer who had undergone rectal magnetic resonance imaging (MRI) were included. The rectal MRI consisted of T2-weighted images in three planes, pre- and post-contrast-enhanced T1-weighted images, and axial diffusion-weighted images (b factors, 0, 1,000 s/mm2). Two radiologists reviewed the MRI scans and measured the axial and longitudinal tumor lengths (LTLs), apparent diffusion coefficient (ADC), and relative contrast enhancement [signal intensity (SI) difference of tumor on pre- and post-contrast T1WI/SI of tumor on pre-contrast T1WI]. The associations among the qualitative data (tumor stage, node stage, lymphatic invasion, venous invasion, and perineural invasion), quantitative data (tumor length, ADC, relative contrast enhancement) and KRAS mutations were statistically analyzed by Fisher's exact test for the qualitative data and by the Mann-Whitney U test for the quantitative data. An area under receiver operating characteristic curve (AUC) was considered as the diagnostic performance for the prediction of KRAS mutation. Molecular-biologic results served as the reference standard. RESULTS: The ratio of axial to LTL in the KRAS-mutant group (n=41) was higher than that in the wild-type group (n=34) (0.29±0.15; 0.22±0.08, P=0.0117). The AUC was 0.640 (95% CI, 0.520 to 0.747, P=0.0292) with an estimated maximum accuracy of 64%. The mean ADC of the mutant group was not significantly different from that of the wild-type group [(0.95±0.17)×10-3 mm2/s; (0.96±0.17)×10-3 mm2/s, P=0.6505]. The relative contrast enhancement showed no significant difference between the two groups (1.66±0.93, 1.35±0.84, P=0.1581). The other qualitative findings also did not show any significant difference (P>0.05). CONCLUSIONS: The ratio of axial to LTL showed a significant difference according to KRAS mutation in patients with primary rectal cancer. However, it showed a low accuracy of 64% for prediction of KRAS mutation.
BACKGROUND: To evaluate the association between various radiologic-pathologic findings and oncogenic Kirsten-ras (KRAS) mutation in patients with primary rectal cancer. METHODS: Seventy-five patients with primary rectal cancer who had undergone rectal magnetic resonance imaging (MRI) were included. The rectal MRI consisted of T2-weighted images in three planes, pre- and post-contrast-enhanced T1-weighted images, and axial diffusion-weighted images (b factors, 0, 1,000 s/mm2). Two radiologists reviewed the MRI scans and measured the axial and longitudinal tumor lengths (LTLs), apparent diffusion coefficient (ADC), and relative contrast enhancement [signal intensity (SI) difference of tumor on pre- and post-contrast T1WI/SI of tumor on pre-contrast T1WI]. The associations among the qualitative data (tumor stage, node stage, lymphatic invasion, venous invasion, and perineural invasion), quantitative data (tumor length, ADC, relative contrast enhancement) and KRAS mutations were statistically analyzed by Fisher's exact test for the qualitative data and by the Mann-Whitney U test for the quantitative data. An area under receiver operating characteristic curve (AUC) was considered as the diagnostic performance for the prediction of KRAS mutation. Molecular-biologic results served as the reference standard. RESULTS: The ratio of axial to LTL in the KRAS-mutant group (n=41) was higher than that in the wild-type group (n=34) (0.29±0.15; 0.22±0.08, P=0.0117). The AUC was 0.640 (95% CI, 0.520 to 0.747, P=0.0292) with an estimated maximum accuracy of 64%. The mean ADC of the mutant group was not significantly different from that of the wild-type group [(0.95±0.17)×10-3 mm2/s; (0.96±0.17)×10-3 mm2/s, P=0.6505]. The relative contrast enhancement showed no significant difference between the two groups (1.66±0.93, 1.35±0.84, P=0.1581). The other qualitative findings also did not show any significant difference (P>0.05). CONCLUSIONS: The ratio of axial to LTL showed a significant difference according to KRAS mutation in patients with primary rectal cancer. However, it showed a low accuracy of 64% for prediction of KRAS mutation.
Authors: Shandra Bipat; Afina S Glas; Frederik J M Slors; Aeilko H Zwinderman; Patrick M M Bossuyt; Jaap Stoker Journal: Radiology Date: 2004-07-23 Impact factor: 11.105
Authors: M J Lahaye; S M E Engelen; P J Nelemans; G L Beets; C J H van de Velde; J M A van Engelshoven; R G H Beets-Tan Journal: Semin Ultrasound CT MR Date: 2005-08 Impact factor: 1.875
Authors: M Yashiro; J M Carethers; L Laghi; K Saito; P Slezak; E Jaramillo; C Rubio; K Koizumi; K Hirakawa; C R Boland Journal: Cancer Res Date: 2001-03-15 Impact factor: 12.701
Authors: Derek J Jonker; Chris J O'Callaghan; Christos S Karapetis; John R Zalcberg; Dongsheng Tu; Heather-Jane Au; Scott R Berry; Marianne Krahn; Timothy Price; R John Simes; Niall C Tebbutt; Guy van Hazel; Rafal Wierzbicki; Christiane Langer; Malcolm J Moore Journal: N Engl J Med Date: 2007-11-15 Impact factor: 91.245
Authors: Christos S Karapetis; Shirin Khambata-Ford; Derek J Jonker; Chris J O'Callaghan; Dongsheng Tu; Niall C Tebbutt; R John Simes; Haji Chalchal; Jeremy D Shapiro; Sonia Robitaille; Timothy J Price; Lois Shepherd; Heather-Jane Au; Christiane Langer; Malcolm J Moore; John R Zalcberg Journal: N Engl J Med Date: 2008-10-23 Impact factor: 91.245